Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology

Biological medical products are drugs whose active components are produced only by living, genetically modified organisms or live cell cultures. Patents and exclusivity for most biopharmaceuticals has either expired or will expire soon, which enables biotechnological companies to introduce similar b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mularczyk, Aldona, Gonciarz, Maciej, Bartnik, Witold, Durlik, Marek, Eder, Piotr, Gąsiorowska, Anita, Linke, Krzysztof, Łodyga, Michał, Łykowska-Szuber, Liliana, Małecka-Panas, Ewa, Pawlik, Magdalena, Radwan, Piotr, Rydzewska, Grażyna
Formato: Artigo
Idioma:Inglês
Publicado: Termedia Publishing House 2014
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027845/
https://ncbi.nlm.nih.gov/pubmed/24868291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2014.40842
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares